155 related articles for article (PubMed ID: 36402574)
1. Thyroid incidentalomas.
Jiskra J
Vnitr Lek; 2022; 68(7):465-474. PubMed ID: 36402574
[TBL] [Abstract][Full Text] [Related]
2. ACR TI-RADS and ATA US scores are helpful for the management of thyroid nodules with indeterminate cytology.
Barbosa TLM; Junior COM; Graf H; Cavalvanti T; Trippia MA; da Silveira Ugino RT; de Oliveira GL; Granella VH; de Carvalho GA
BMC Endocr Disord; 2019 Oct; 19(1):112. PubMed ID: 31664992
[TBL] [Abstract][Full Text] [Related]
3. Malignancy rates for Bethesda III and IV thyroid nodules: a retrospective study of the correlation between fine-needle aspiration cytology and histopathology.
Yaprak Bayrak B; Eruyar AT
BMC Endocr Disord; 2020 Apr; 20(1):48. PubMed ID: 32293401
[TBL] [Abstract][Full Text] [Related]
4. Follow-Up Strategies for Thyroid Nodules with Benign Cytology on Ultrasound-Guided Fine Needle Aspiration: Malignancy Rates of Management Guidelines Using Ultrasound Before and After the Era of the Bethesda System.
Yoon JH; Lee HS; Kim EK; Moon HJ; Park VY; Kwak JY
Thyroid; 2019 Sep; 29(9):1227-1236. PubMed ID: 31359839
[No Abstract] [Full Text] [Related]
5. Can the American Thyroid Association, K-Tirads, and Acr-Tirads Ultrasound Classification Systems Be Used to Predict Malignancy in Bethesda Category IV Nodules?
Yang W; Fananapazir G; LaRoy J; Wilson M; Campbell MJ
Endocr Pract; 2020 Sep; 26(9):945-952. PubMed ID: 33471698
[TBL] [Abstract][Full Text] [Related]
6. Ultrasound criteria (EU-TIRADS) to identify thyroid nodule malignancy risk in adolescents. Correlation with cyto-histological findings.
Yeste Fernández D; Vega Amenabar E; Coma Muñoz A; Arciniegas Vallejo L; Clemente León M; Planes-Conangla M; Iglesias Felip C; Sábado Álvarez C; Guillén Burrieza G; Campos-Martorell A
Endocrinol Diabetes Nutr (Engl Ed); 2021 Dec; 68(10):728-734. PubMed ID: 34924161
[TBL] [Abstract][Full Text] [Related]
7. Approach to Bethesda system category III thyroid nodules according to US-risk stratification.
Kim J; Shin JH; Oh YL; Hahn SY; Park KW
Endocr J; 2022 Jan; 69(1):67-74. PubMed ID: 34408101
[TBL] [Abstract][Full Text] [Related]
8. The relationship between ultrasound-based TIRADS and BETHESDA categories in patients undergoing thyroid biopsy.
Aksoy SH; Uygun O; Yurdaisik I; Ates L; Aydin S
Clin Exp Med; 2022 Nov; 22(4):661-666. PubMed ID: 35022917
[TBL] [Abstract][Full Text] [Related]
9. Repeat Diagnoses of Bethesda Category III Thyroid Nodules: What To Do Next?
Yoo MR; Gweon HM; Park AY; Cho KE; Kim JA; Youk JH; Son EJ
PLoS One; 2015; 10(6):e0130138. PubMed ID: 26115096
[TBL] [Abstract][Full Text] [Related]
10. Does a higher American College of Radiology Thyroid Imaging Reporting and Data System (ACR TI-RADS) score forecast an increased risk of malignancy? A correlation study of ACR TI-RADS with FNA cytology in the evaluation of thyroid nodules.
Modi L; Sun W; Shafizadeh N; Negron R; Yee-Chang M; Zhou F; Simsir A; Sheth S; Brandler TC
Cancer Cytopathol; 2020 Jul; 128(7):470-481. PubMed ID: 32078249
[TBL] [Abstract][Full Text] [Related]
11. Risk stratification of the thyroid nodule with Bethesda indeterminate cytology, category III, IV, V on the one surgeon-performed US-guided fine-needle aspiration with 27-gauge needle, verified by histopathology of thyroidectomy: the additional value of one surgeon-performed elastography.
Sengul D; Sengul I; Van Slycke S
Acta Chir Belg; 2019 Feb; 119(1):38-46. PubMed ID: 30606092
[TBL] [Abstract][Full Text] [Related]
12. The value of conventional sonography and ultrasound elastography in decision-making for thyroid nodules in different categories of the Bethesda system for reporting thyroid cytopathology.
Wu Q; Li Y; Liu Y; Shen J; Wang Y; Yi X; Hu B
Clin Hemorheol Microcirc; 2020; 74(3):255-266. PubMed ID: 31683465
[TBL] [Abstract][Full Text] [Related]
13. The Value of Ultrasound-Guided Fine-Needle Aspiration Cytology Combined with Puncture Feeling in the Diagnosis of Thyroid Nodules.
Li L; Chen X; Li P; Liu Y; Ma X; Ye YQ
Acta Cytol; 2021; 65(5):368-376. PubMed ID: 34350849
[TBL] [Abstract][Full Text] [Related]
14. Ultrasound classification of thyroid nodules: does size matter?
Sakajiri RK; Rahal Junior A; Francisco Neto MJ; Queiroz MRG; Garcia RG; Martins LAL; Malerbi DAC
Einstein (Sao Paulo); 2022; 20():eAO6747. PubMed ID: 35584446
[TBL] [Abstract][Full Text] [Related]
15. Clinico-pathological Correlation of Thyroid Nodule Ultrasound and Cytology Using the TIRADS and Bethesda Classifications.
Singaporewalla RM; Hwee J; Lang TU; Desai V
World J Surg; 2017 Jul; 41(7):1807-1811. PubMed ID: 28251273
[TBL] [Abstract][Full Text] [Related]
16. Cytology-Ultrasonography Risk-Stratification Scoring System Based on Fine-Needle Aspiration Cytology and the Korean-Thyroid Imaging Reporting and Data System.
Hong MJ; Na DG; Baek JH; Sung JY; Kim JH
Thyroid; 2017 Jul; 27(7):953-959. PubMed ID: 28463597
[TBL] [Abstract][Full Text] [Related]
17. Thyroid Nodules: Nondiagnostic Cytologic Results according to Thyroid Imaging Reporting and Data System before and after Application of the Bethesda System.
Yoon JH; Lee HS; Kim EK; Moon HJ; Kwak JY
Radiology; 2015 Aug; 276(2):579-87. PubMed ID: 25848904
[TBL] [Abstract][Full Text] [Related]
18. Combination of ultrasound and molecular testing in malignancy risk estimate of Bethesda category IV thyroid nodules: results from a single-institution prospective study.
Marina M; Zatelli MC; Goldoni M; Del Rio P; Corcione L; Martorana D; Percesepe A; Bonatti F; Mozzoni P; Crociara A; Ceresini G
J Endocrinol Invest; 2021 Dec; 44(12):2635-2643. PubMed ID: 33860907
[TBL] [Abstract][Full Text] [Related]
19. Thyroid imaging reporting and data system in assessment of cytological Bethesda Category III thyroid nodules.
Mao F; Xu HX; Zhao CK; Bo XW; Li XL; Li DD; Liu BJ; Zhang YF; Xu JM; Qu S
Clin Hemorheol Microcirc; 2017; 65(2):163-173. PubMed ID: 27589516
[TBL] [Abstract][Full Text] [Related]
20. Risk stratification of thyroid nodules with Bethesda category III results on fine-needle aspiration cytology: The additional value of acoustic radiation force impulse elastography.
Zhao CK; Xu HX; Xu JM; Sun CY; Chen W; Liu BJ; Bo XW; Wang D; Qu S
Oncotarget; 2017 Jan; 8(1):1580-1592. PubMed ID: 27906671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
